Hope Grows for Patients with Sickle Cell Disease

March 03, 2014


Advances in research and treatment are changing sickle cell disease from an inherited condition that often condemned children to painful and short lives into a condition that can be managed with less pain and a longer life expectancy, the Washington Post reports.  

“We are making progress,” said Dana-Farber/Boston Children’s hematologist David Nathan, MD, president emeritus of Dana-Farber Cancer Institute and physician-in-chief emeritus of Boston Children’s Hospital. “You can get leaps, but most of the time it’s dog’s work. It is a combination of basic science and clinical investigators who are persistent.”  

Read the full story.  

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo